fibrinogen has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.69) | 18.7374 |
1990's | 12 (30.77) | 18.2507 |
2000's | 9 (23.08) | 29.6817 |
2010's | 9 (23.08) | 24.3611 |
2020's | 6 (15.38) | 2.80 |
Authors | Studies |
---|---|
Ashrani, AA; Greenmyer, JR; Rodriguez, V; Warad, D; Wyatt, KD | 1 |
Albertsen, BK; Andersson, NG; Hoffmann, M; Huurre, A; Jarvis, KB; Joelsson, J; Långström, S; Lohi, O; Mølle, I; Overgaard, U; Ranta, S; Rathe, M; Saulyte Trakymiene, S; Vepsäläinen, K; Vogt, H | 1 |
Albertsen, BK; Bjerre, J; Grell, K; Hvitfeldt, L; Højfeldt, SG; Wehner, PS | 1 |
Balsat, M; Boissel, N; Bonmati, C; Cacheux, V; Caillot, D; Chalandon, Y; Chantepie, S; Chevallier, P; de Gunzburg, N; Dombret, H; Frayfer, J; Huguet, F; Hunault-Berger, M; Ifrah, N; Lheritier, V; Marolleau, JP; Orvain, C; Pabst, T; Tavernier, E | 1 |
Akyol, Ş; Erdoğmuş, NA; Karakükçü, M; Özcan, A; Patıroğlu, T; Samur, B; Ünal, E | 1 |
Ito, T; Kojima, K; Nakamura, M; Ogasawara, F; Saeki, K; Taniguti, A; Togitani, K | 1 |
Cortelezzi, A; Fracchiolla, NS; Sciumè, M | 1 |
Felker, J; Lew, G; Patel, KN; Raikar, SS; Sidonio, RF | 1 |
Al-Hadithi, RH; Al-Khalidi, AN; Alqasim, AMZ | 1 |
Casale, F; Colombini, A; Consarino, C; Corallo, PC; De Leonardis, F; Giordano, P; Grassi, M; Luciani, M; Mastrodicasa, E; Micalizzi, C; Mura, RM; Notarangelo, LD; Onofrillo, D; Petruzziello, F; Pollio, B; Putti, MC; Rizzari, C; Santoro, N; Saracco, P; Tafuri, S; Testi, AM | 1 |
Afeich, C; Bonnefoy, A; Laverdière, C; Leclerc, JM; Merlen, C; Rivard, GE; Théorêt, Y | 1 |
Frisk, T; Heyman, MM; Jahnukainen, K; Mäkipernaa, AM; Petrini, P; Ranta, S; Saarinen-Pihkala, UM; Söderhäll, S; Taskinen, M | 1 |
Bonnefoy, A; Dedeken, L; Laverdière, C; Leclerc, JM; Merlen, C; Rivard, GE; Wagner, E | 1 |
Feng, R; Hao, XX; Wei, XL; Wei, YQ; Xu, LW; Zhou, QJ | 1 |
Balwierz, W; Czogała, M; Rogatko, I; Sztefko, K | 1 |
Bernard, M; Bologna, S; Bulabois, CE; Chevallier, P; Cornillon, J; Delain, M; Gruel, Y; Hunault-Berger, M; Ifrah, N; Lafon, I; Maakaroun, A; Padrazzi, B; Tizon, A | 1 |
Abbott, LS; Barnard, DR; Berman, JN; Deevska, M; Dix, D; Fernandez, CV; Fitzgerald, C; Parker, L; Price, VE; Wang, H; Yhap, M | 1 |
Böhles, H; Jacobi, G; Kieslich, M; Lanfermann, H; Porto, L; Schwabe, D | 1 |
Gürgey, A; Kirazli, S; Toksöz, H; Unal, S | 1 |
Ahrén, B; Björk, J; Cavallin-Ståhl, E; Erfurth, EM; Garwicz, S; Link, K; Moëll, C; Thilén, U | 1 |
Beinart, G; Damon, L | 1 |
Guo, T; Hu, Y; Wei, W; Yang, R; Yang, Y | 1 |
Appel, IM; Pieters, R; Stigter, R; van Kessel-Bakvis, C | 1 |
Andrew, ME; Eves, M; Halton, JM; Mitchell, LG; Vegh, P | 1 |
de Stefano, V; Gugliotta, L; Leone, G; Mandelli, F; Mazzucconi, MG | 1 |
Godal, HC; Sletnes, KE; Wisløff, F | 1 |
Astruc, D; Babin-Boilletot, A; Cazenave, JP; Grunebaum, L; Lutz, P; Nowak, V; Wiesel, ML | 1 |
Dekker, I; Hählen, K; Hop, WC; Risseeuw-Appel, IM | 1 |
Ahlke, E; Boos, J; Nowak-Göttl, U; Schulze-Westhoff, P | 1 |
Andreeff, M; Cortes, J; Kantarjian, H; Keating, M; Koller, C; Kornblau, S; O'Brien, S; Pierce, S; Sarris, A; Smith, T | 1 |
Bel Haj Ali, Z; Ben Abid, H; Ben Lakhal, R; Ben Othman, T; Dellagi, K; Gouider, E; Guermazi, S; Hafsia, A; Hafsia, R; Jeddi, R; Meddeb, B | 1 |
Annino, L; Defazio, D; Gugliotta, L; Leone, G; Mandelli, F; Mattioli-Belmonte, M; Mazzucconi, MG; Tura, S | 1 |
Advani, SH; Bhat, SV; Hegde, U; Puniyani, RR; Rao, S; Sharma, K | 1 |
Fernandez-Rañada, JM; Gómez, N; López, J; Solano, C | 1 |
Andreeff, M; Berman, E; Filippa, D; Gansbacher, B; Gee, T; Kempin, S; Little, C; Michaeli, J; Sarris, AH; Straus, D | 1 |
Castaman, G; Dini, E; Rodeghiero, F | 1 |
Castaman, G; Castronovo, S; Cortesi, S; Dini, E; Quaglio, R; Rodeghiero, F; Soffiati, G | 1 |
Muntean, W; Zaunschirm, A | 1 |
Bianchini, B; Coccheri, S; Legnani, C; Palareti, G; Pession, A; Poggi, M; Vecchi, V | 1 |
7 trial(s) available for fibrinogen and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Topics: Adult; Asparaginase; Female; Fibrinogen; Follow-Up Studies; Heparin; Humans; Incidence; Induction Chemotherapy; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Venous Thromboembolism | 2020 |
Antithrombin and fibrinogen levels as predictors for plasma L-asparaginase activity in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antithrombin Proteins; Asparaginase; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 2019 |
Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antithrombin III Deficiency; Asparaginase; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2013 |
Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.
Topics: Adolescent; alpha-Macroglobulins; Antithrombin III; Antithrombin III Deficiency; Asparaginase; Blood Coagulation; Child; Child, Preschool; Fibrinogen; Hemostasis; Heparin Cofactor II; Humans; Plasma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein C; Protein S; Prothrombin | 1994 |
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
Topics: Adult; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Blood Coagulation; Cyclophosphamide; Daunorubicin; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Humans; Peptide Hydrolases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Prothrombin; Vincristine | 1993 |
[Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children].
Topics: Adrenal Cortex Hormones; Asparaginase; Child; Erwinia; Escherichia coli; Fibrinogen; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.
Topics: Asparaginase; Blood Coagulation; Blood Coagulation Factors; Child; Child, Preschool; Erwinia; Escherichia coli; Female; Fibrinogen; Humans; Male; Partial Thromboplastin Time; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein C | 1994 |
32 other study(ies) available for fibrinogen and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Management Practices for Asparaginase-associated Coagulopathy: A Survey of Pediatric Oncologists.
Topics: Anticoagulants; Antithrombin III; Antithrombins; Asparaginase; Blood Coagulation Disorders; Child; Fibrinogen; Humans; Oncologists; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2022 |
A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management.
Topics: Anticoagulants; Antithrombins; Blood Coagulation Disorders; Child; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Venous Thromboembolism; Young Adult | 2022 |
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment.
Topics: Adolescent; Antineoplastic Agents; Antithrombins; Asparaginase; Blood Coagulation; Child; Child, Preschool; Fibrinogen; Humans; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
Congenital afibrinogenemia in a 4-year-old girl complicated with acute lymphoblastic leukemia.
Topics: Afibrinogenemia; Child, Preschool; Female; Fibrinogen; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2020 |
[Acquired hypofibrinogenemia in patients with leukemia during steroid therapy].
Topics: Afibrinogenemia; Asparaginase; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2021 |
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Humans; Imatinib Mesylate; Incidence; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
Topics: Afibrinogenemia; Asparaginase; Child; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Induction Chemotherapy; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2018 |
Coagulopathic side effect of L-asparaginase on fibrinogen level in childhood acute lymphoblastic leukemia during induction phase.
Topics: Asparaginase; Child; Child, Preschool; Female; Fibrinogen; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies | 2019 |
Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children With Acute Lymphoblastic Leukemia: Results of a Retrospective Survey.
Topics: Adolescent; Afibrinogenemia; Child; Child, Preschool; Female; Fibrinogen; Humans; Male; Plasma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2019 |
L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antithrombins; Asparaginase; Child; Child, Preschool; Febrile Neutropenia; Female; Fibrinogen; Humans; Infant; Male; Mannose-Binding Lectin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombosis | 2015 |
[Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors].
Topics: Adult; Antineoplastic Agents; Asparaginase; Blood Coagulation; Fibrinogen; Hemorrhage; Humans; Leukocyte Count; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors | 2016 |
Antithrombin III as the Indicator of L-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Area Under Curve; Asparaginase; Biomarkers; Blood Coagulation Tests; Child; Child, Preschool; Drug Monitoring; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; ROC Curve | 2017 |
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antithrombins; Asparaginase; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Thrombosis; Treatment Outcome | 2008 |
The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.
Topics: Adolescent; Asparaginase; British Columbia; Central Nervous System; Child; Child, Preschool; Costs and Cost Analysis; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Infant; Male; Nova Scotia; Outcome Assessment, Health Care; Plasma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Sex Factors; Thrombosis | 2009 |
Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antithrombin III; Asparaginase; Brain; Brain Diseases; Cerebral Hemorrhage; Child; Female; Fibrinogen; Headache; Humans; Magnetic Resonance Imaging; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures; Venous Thrombosis | 2003 |
The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia. A preliminary study.
Topics: Adolescent; Child; Child, Preschool; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Methylprednisolone; Plasminogen Activator Inhibitor 1; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2004 |
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Topics: Adolescent; Apolipoproteins B; Arginine; Blood Glucose; Body Height; Cardiovascular Diseases; Carotid Arteries; Child; Child, Preschool; Cholesterol, LDL; Echocardiography, Doppler; Exercise; Female; Fibrinogen; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Insulin; Leptin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Risk Factors; Triglycerides | 2004 |
Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Asparaginase; Fibrinogen; Humans; Medical Records; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Thrombosis | 2004 |
Fribrinolysis kinetics and its application.
Topics: Adolescent; Adult; Blood Coagulation; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Crotalid Venoms; Drug Monitoring; Female; Fibrinogen; Fibrinolysis; Humans; Kinetics; Leukemia, Myeloid, Acute; Male; Middle Aged; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Spectrophotometry, Ultraviolet; Thrombin; Time Factors; Transfection; Urokinase-Type Plasminogen Activator | 2007 |
Influence of two different regimens of concomitant treatment with asparaginase and dexamethasone on hemostasis in childhood acute lymphoblastic leukemia.
Topics: Adrenal Cortex Hormones; Asparaginase; Coagulants; Combined Modality Therapy; Dexamethasone; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Thrombosis; Time Factors | 2007 |
Disseminated intravascular coagulation (DIC) in adult patients with acute leukaemia.
Topics: Adolescent; Adult; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation.
Topics: alpha-2-Antiplasmin; Antineoplastic Agents; Asparaginase; Blood Coagulation; Child; Child, Preschool; Dose-Response Relationship, Drug; Escherichia coli; Factor V; Fibrinogen; Fibrinolysis; Humans; Mutation; Plasminogen; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies | 1996 |
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Topics: Adult; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Leukocyte Count; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Thrombosis | 1996 |
[Atypical defibrination syndromes and acute leukemias with a t(9,22) translocation, apropos of 2 cases].
Topics: Adult; alpha-2-Antiplasmin; Antithrombin III; Diagnosis, Differential; Disseminated Intravascular Coagulation; Factor V Deficiency; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Monocytic, Acute; Male; Neoplastic Stem Cells; Plasminogen; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome | 2001 |
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Thrombin; Thrombosis; Vincristine | 1992 |
Blood viscosity parameter correlation with types of leukemia.
Topics: Blood Sedimentation; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Hemoglobins; Humans; L-Lactate Dehydrogenase; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Platelet Aggregation; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
Acute lymphoblastic leukemia: hypofibrinogenemia with a low incidence of clinical complications is often found during induction remission therapy.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1992 |
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia.
Topics: Adult; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Philadelphia Chromosome; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prothrombin Time; Remission Induction | 1992 |
Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
Topics: Adolescent; Adult; Asparaginase; Biomarkers; Blood Coagulation; Child; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Thrombin | 1990 |
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunoassay; Thioguanine; Time Factors | 1989 |
Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Blood Coagulation Disorders; Blood Coagulation Tests; Child; Fibrinogen; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1986 |
Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
Topics: Asparaginase; Blood Coagulation Tests; Child; Child, Preschool; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Male; Plasminogen; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1988 |